PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-04-01

Date Title Company
01-Apr-2022 Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer’s and Parkinson’s Disease Models Asceneuron
01-Apr-2022 EUROAPI listing on Euronext Paris expected on May 6, 2022 Sanofi
01-Apr-2022 Merck Provides Update on FDA Review of Supplemental Biologics License Application for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for Use in Infants and Children Businesswire
01-Apr-2022 Freeline Reports Full Year 2021 Financial Results and Business Highlights Freeline Therapeutics Holdings plc
01-Apr-2022 Merck and Ridgeback to Present Data Demonstrating That Treatment With LAGEVRIO™ (molnupiravir) Was Associated With More Rapid Elimination of Infectious SARS-CoV-2 Than Placebo Businesswire
01-Apr-2022 Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services Medidata
01-Apr-2022 Hyloris Launches Equity Offering by Means of a Private Placement Via an Accelerated Bookbuild Offering Hyloris Pharmaceuticals SA
01-Apr-2022 Healthtech startup accelerating genetic disease research raises $11M in Series A funding round Sano Genetics
01-Apr-2022 Future investment plan - HCS Pharma announces the success of the ONCO3D project to discover new anti-cancer therapies HCS Pharma
01-Apr-2022 ViiV Healthcare announces US FDA approval of Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV ViiV Healthcare
01-Apr-2022 HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD), suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-release Ketamine (KET01) Study HMNC Brain Health
01-Apr-2022 The Worldwide Anti-Osteoporosis Therapy & Fracture Healing Industry is Expected to Reach $19 Billion by 2027 - ResearchAndMarkets.com Businesswire
01-Apr-2022 Lead Candidate Partners with List Biotherapeutics to Support Specialist Recruitment for $125M US Microbiome Manufacturing Facility Lead Candidate
01-Apr-2022 The Worldwide Clinical Trials Industry is Expected to Reach $49+ Billion by 2026 - ResearchAndMarkets.com Businesswire
01-Apr-2022 Global CRISPR Gene Editing Market Research Report 2022 - ResearchAndMarkets.com Businesswire
01-Apr-2022 Europe $49.52 Bn Active Pharmaceutical Ingredients Markets, 2021-2022 & 2028 - ResearchAndMarkets.com Businesswire
01-Apr-2022 Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) Drug Analysis Report 2022: In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Player - ResearchAndMarkets.com Businesswire
01-Apr-2022 Transforming Growth Factor Beta 1 (TGFB1) Drugs Market Research Report 2022: Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - ResearchAndMarkets.com Businesswire
01-Apr-2022 European Clinical Laboratory Services Market 2022: Increased Support for Europe's Beating Cancer Plan for Improved Early Detection, Treatment and Care - ResearchAndMarkets.com Businesswire
01-Apr-2022 Global Chromatography Software Market to 2027 - Rising Applications of Chromatography in Different Fields are Driving Growth - ResearchAndMarkets.com Businesswire